Abbott Laboratories Stock Price, News & Analysis (NYSE:ABT)

$60.17 +0.67 (+1.13 %)
(As of 02/20/2018 06:30 AM ET)
Previous Close$59.50
Today's Range$59.33 - $60.54
52-Week Range$42.31 - $64.60
Volume7.85 million shs
Average Volume7.71 million shs
Market Capitalization$105.08 billion
P/E Ratio231.43
Dividend Yield1.88%
Beta1.55

About Abbott Laboratories (NYSE:ABT)

Abbott Laboratories logoAbbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Receive ABT News and Ratings via Email

Sign-up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:ABT
CUSIP00282410
Phone224-667-6100

Debt

Debt-to-Equity Ratio0.72%
Current Ratio2.69%
Quick Ratio2.26%

Price-To-Earnings

Trailing P/E Ratio231.431978153006
Forward P/E Ratio21.04
P/E Growth1.81

Sales & Book Value

Annual Sales$27.39 billion
Price / Sales3.82
Cash Flow$3.66 per share
Price / Cash16.43
Book Value$12.04 per share
Price / Book5.00

Profitability

Trailing EPS$0.26
Net Income$477 million
Net Margins1.74%
Return on Equity13.80%
Return on Assets6.15%

Miscellaneous

Employees75,000
Outstanding Shares1,740,600,000

Abbott Laboratories (NYSE:ABT) Frequently Asked Questions

What is Abbott Laboratories' stock symbol?

Abbott Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABT."

How often does Abbott Laboratories pay dividends? What is the dividend yield for Abbott Laboratories?

Abbott Laboratories announced a quarterly dividend on Friday, February 16th. Shareholders of record on Friday, April 13th will be given a dividend of $0.28 per share on Tuesday, May 15th. This represents a $1.12 annualized dividend and a yield of 1.86%. The ex-dividend date of this dividend is Thursday, April 12th. View Abbott Laboratories' Dividend History.

How were Abbott Laboratories' earnings last quarter?

Abbott Laboratories (NYSE:ABT) released its quarterly earnings results on Wednesday, January, 24th. The healthcare product maker reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.73 by $0.01. The healthcare product maker earned $7.59 billion during the quarter, compared to analyst estimates of $7.38 billion. Abbott Laboratories had a return on equity of 13.80% and a net margin of 1.74%. The firm's revenue for the quarter was up 42.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.65 EPS. View Abbott Laboratories' Earnings History.

When will Abbott Laboratories make its next earnings announcement?

Abbott Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April, 18th 2018. View Earnings Estimates for Abbott Laboratories.

What guidance has Abbott Laboratories issued on next quarter's earnings?

Abbott Laboratories issued an update on its FY18 earnings guidance on Wednesday, January, 24th. The company provided earnings per share guidance of $2.80-2.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.83. Abbott Laboratories also updated its Q1 guidance to $0.57-0.59 EPS.

Where is Abbott Laboratories' stock going? Where will Abbott Laboratories' stock price be in 2018?

18 analysts have issued 12 month price targets for Abbott Laboratories' stock. Their predictions range from $45.00 to $80.00. On average, they anticipate Abbott Laboratories' share price to reach $67.00 in the next year. View Analyst Ratings for Abbott Laboratories.

Are investors shorting Abbott Laboratories?

Abbott Laboratories saw a increase in short interest in the month of January. As of January 31st, there was short interest totalling 13,229,656 shares, an increase of 36.6% from the January 12th total of 9,685,399 shares. Based on an average daily volume of 8,362,357 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.8% of the company's shares are sold short.

Who are some of Abbott Laboratories' key competitors?

Who are Abbott Laboratories' key executives?

Abbott Laboratories' management team includes the folowing people:

  • Miles D. White, Chairman of the Board, Chief Executive Officer (Age 62)
  • Brian B. Yoor, Chief Financial Officer, Executive Vice President - Finance (Age 47)
  • Michael T. Rousseau, President - Cardiovascular and Neuromodulation (Age 61)
  • Hubert L. Allen, Executive Vice President, General Counsel, Secretary (Age 51)
  • Stephen R. Fussell, Executive Vice President - Human Resources (Age 59)
  • Brian J. Blaser, Executive Vice President - Diagnostics Products (Age 52)
  • John M. Capek Ph.D., Executive Vice President - Ventures (Age 55)
  • Robert B. Ford, Executive Vice President - Medical Devices (Age 43)
  • Heather L. Mason, Executive Vice President - Nutritional Products (Age 56)
  • Roger M Bird, Senior Vice President - U.S. Nutrition (Age 60)

Who owns Abbott Laboratories stock?

Abbott Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.33%), Bank of New York Mellon Corp (1.80%), Geode Capital Management LLC (1.04%), Macquarie Group Ltd. (0.75%), Alliancebernstein L.P. (0.72%) and TIAA CREF Investment Management LLC (0.62%). Company insiders that own Abbott Laboratories stock include Alejandro D Wellisch, Brian B Yoor, Brian J Blaser, Daniel Gesua Sive Salvadori, Deepak S Nath, Heather L Mason, Hubert L Allen, Jaime Contreras, Jared Watkin, Joseph J Manning, Michael J Warmuth, Miles D White, Robert B Ford, Robert E Funck, Roger Bird, Sally E Blount, Sharon J Bracken and Stephen R Fussell. View Institutional Ownership Trends for Abbott Laboratories.

Who sold Abbott Laboratories stock? Who is selling Abbott Laboratories stock?

Abbott Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Flossbach Von Storch AG, Independent Franchise Partners LLP, Rockefeller Financial Services Inc., Teachers Advisors LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp and Macquarie Group Ltd.. Company insiders that have sold Abbott Laboratories company stock in the last year include Alejandro D Wellisch, Brian J Blaser, Daniel Gesua Sive Salvadori, Deepak S Nath, Hubert L Allen, Jaime Contreras, Jared Watkin, Joseph J Manning, Michael J Warmuth, Miles D White, Robert E Funck, Roger Bird, Sharon J Bracken and Stephen R Fussell. View Insider Buying and Selling for Abbott Laboratories.

Who bought Abbott Laboratories stock? Who is buying Abbott Laboratories stock?

Abbott Laboratories' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Amundi Pioneer Asset Management Inc., Bank of Montreal Can, Redmile Group LLC, Gotham Asset Management LLC, Schwab Charles Investment Management Inc., Geode Capital Management LLC and SG Americas Securities LLC. Company insiders that have bought Abbott Laboratories stock in the last two years include Brian J Blaser, Miles D White, Robert B Ford and Sally E Blount. View Insider Buying and Selling for Abbott Laboratories.

How do I buy Abbott Laboratories stock?

Shares of Abbott Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Abbott Laboratories' stock price today?

One share of Abbott Laboratories stock can currently be purchased for approximately $60.17.

How big of a company is Abbott Laboratories?

Abbott Laboratories has a market capitalization of $105.08 billion and generates $27.39 billion in revenue each year. The healthcare product maker earns $477 million in net income (profit) each year or $0.26 on an earnings per share basis. Abbott Laboratories employs 75,000 workers across the globe.

How can I contact Abbott Laboratories?

Abbott Laboratories' mailing address is 100 ABBOTT PARK ROAD D-322 AP6D, ABBOTT PARK IL, 60064. The healthcare product maker can be reached via phone at 224-667-6100.


MarketBeat Community Rating for Abbott Laboratories (ABT)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  626 (Vote Outperform)
Underperform Votes:  475 (Vote Underperform)
Total Votes:  1,101
MarketBeat's community ratings are surveys of what our community members think about Abbott Laboratories and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Abbott Laboratories (NYSE:ABT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.782.812.642.69
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $67.00$61.27$57.64$52.83
Price Target Upside: 6.60% upside3.30% upside3.36% upside6.07% upside

Abbott Laboratories (NYSE:ABT) Consensus Price Target History

Price Target History for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/30/2018ArgusBoost Price TargetBuy$66.00 -> $80.00LowView Rating Details
1/30/2018CitigroupBoost Price TargetNeutral -> Neutral$59.00 -> $64.00LowView Rating Details
1/25/2018BarclaysBoost Price TargetOverweight -> Overweight$66.00 -> $70.00LowView Rating Details
1/25/2018GuggenheimReiterated RatingBuy$72.00LowView Rating Details
1/25/2018Royal Bank of CanadaReiterated RatingBuy$67.00LowView Rating Details
1/25/2018Leerink SwannReiterated RatingMarket Perform$60.00 -> $68.00LowView Rating Details
1/25/2018JPMorgan Chase & Co.Boost Price TargetOverweight -> Overweight$65.00 -> $69.00HighView Rating Details
1/25/2018Morgan StanleyBoost Price TargetOverweight -> Overweight$67.00 -> $70.00HighView Rating Details
1/25/2018Wells Fargo & CoBoost Price TargetOutperform$66.00 -> $70.00MediumView Rating Details
1/25/2018BMO Capital MarketsBoost Price TargetOutperform -> Outperform$65.00 -> $70.00MediumView Rating Details
1/25/2018Stifel NicolausBoost Price TargetBuy -> Buy$63.00 -> $71.00MediumView Rating Details
1/25/2018William BlairUpgradeMarket Perform -> OutperformMediumView Rating Details
1/24/2018Bank of AmericaBoost Price Target$60.00 -> $70.00HighView Rating Details
1/22/2018BTIG ResearchDowngradeBuy -> NeutralMediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$64.00LowView Rating Details
10/19/2017CowenSet Price TargetBuy$55.00 -> $68.00N/AView Rating Details
10/19/2017Jefferies GroupReiterated RatingBuy$65.00N/AView Rating Details
5/16/2017Goldman Sachs GroupInitiated CoverageNeutral -> Neutral$45.00LowView Rating Details
8/9/2016Deutsche BankReiterated RatingBuyN/AView Rating Details
6/21/2016Edward JonesUpgradeHold -> BuyN/AView Rating Details
6/8/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
4/30/2016S&P Equity ResearchReiterated RatingHoldN/AView Rating Details
4/30/2016GabelliReiterated RatingBuyN/AView Rating Details
4/28/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
4/14/2016First GlobalDowngradeOutperform -> MarketperformN/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Abbott Laboratories (NYSE:ABT) Earnings History and Estimates Chart

Earnings by Quarter for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE ABT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/17/2018$0.57N/AView Earnings Details
1/24/2018Q4 2017$0.73$0.74$7.38 billion$7.59 billionViewListenView Earnings Details
10/18/20179/30/2017$0.65$0.66$6.72 billion$6.83 billionViewN/AView Earnings Details
7/20/2017Q2 2017$0.60$0.62$6.63 billion$6.64 billionViewN/AView Earnings Details
4/19/20173/31/2017$0.43$0.48$6.16 billion$6.34 billionViewN/AView Earnings Details
1/25/2017Q416$0.64$0.65$5.41 billion$5.33 billionViewListenView Earnings Details
10/19/2016Q316$0.58$0.59$5.29 billion$5.30 billionViewListenView Earnings Details
7/20/2016Q216$0.53$0.55$5.24 billion$5.30 billionViewListenView Earnings Details
4/20/2016Q116$0.39$0.41$4.77 billion$4.90 billionViewListenView Earnings Details
1/28/2016Q415$0.61$0.62$5.31 billion$5.20 billionViewListenView Earnings Details
10/21/2015Q315$0.53$0.54$5.16 billion$5.15 billionViewListenView Earnings Details
7/22/2015Q215$0.50$0.52$5.15 billion$5.20 billionViewListenView Earnings Details
4/22/2015Q115$0.42$0.47$4.85 billion$4.90 billionViewListenView Earnings Details
1/29/2015Q414$0.68$0.71$5.48 billion$5.36 billionViewListenView Earnings Details
10/22/2014Q314$0.60$0.62$5.62 billion$5.10 billionViewListenView Earnings Details
7/16/2014Q214$0.51$0.54$5.53 billion$5.55 billionViewListenView Earnings Details
4/16/2014Q114$0.36$0.41$5.29 billion$5.24 billionViewListenView Earnings Details
1/22/2014Q413$0.58$0.58$5.72 billion$5.66 billionViewListenView Earnings Details
10/16/2013Q313$0.52$0.55$5.46 billion$5.37 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.44$0.46$5.53 billion$5.45 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.41$0.42$5.42 billion$5.38 billionViewListenView Earnings Details
1/23/2013Q4 2012$1.50$1.51$10.58 billion$10.80 billionViewListenView Earnings Details
10/17/2012$1.28$1.30ViewN/AView Earnings Details
7/18/2012$1.22$1.23ViewN/AView Earnings Details
4/18/2012$1.00$1.03ViewN/AView Earnings Details
1/25/2012$1.44$1.45ViewN/AView Earnings Details
10/19/2011$1.17$1.18ViewN/AView Earnings Details
7/20/2011$1.12$1.12ViewN/AView Earnings Details
4/20/2011$0.90$0.91ViewN/AView Earnings Details
1/26/2011$1.29$1.30ViewN/AView Earnings Details
10/20/2010Q3 2010$1.04$1.05ViewN/AView Earnings Details
7/21/2010Q2 2010$1.00$1.01ViewN/AView Earnings Details
4/21/2010Q1 2010$0.80$0.81ViewN/AView Earnings Details
1/27/2010Q4 2009$1.17$1.18ViewN/AView Earnings Details
10/14/2009Q3 2009$0.90$0.92ViewN/AView Earnings Details
7/15/2009Q2 2009$0.89$0.90ViewN/AView Earnings Details
4/15/2009Q1 2009$0.70$0.73ViewN/AView Earnings Details
1/21/2009Q4 2008$1.06$1.06ViewN/AView Earnings Details
10/15/2008Q3 2008$0.77$0.79ViewN/AView Earnings Details
7/16/2008Q2 2008$0.78$0.84ViewN/AView Earnings Details
4/16/2008Q1 2008$0.63$0.63ViewN/AView Earnings Details
1/23/2008Q4 2007$0.92$0.93ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Abbott Laboratories (NYSE:ABT) Earnings Estimates

2018 EPS Consensus Estimate: $2.85
2019 EPS Consensus Estimate: $3.17
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.57$0.58$0.57
Q2 20183$0.69$0.72$0.71
Q3 20183$0.72$0.76$0.74
Q4 20183$0.81$0.84$0.83
Q1 20192$0.63$0.65$0.64
Q2 20192$0.79$0.79$0.79
Q3 20192$0.82$0.82$0.82
Q4 20192$0.91$0.93$0.92
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Abbott Laboratories (NYSE:ABT) Dividend Information

Next Dividend:5/15/2018
Annual Dividend:$1.12
Dividend Yield:1.86%
Dividend Growth:6.40% (3 Year Average)
Payout Ratio:430.79% (Trailing 12 Months of Earnings)
39.16% (Based on This Year's Estimates)
34.89% (Based on Next Year's Estimates)
Track Record:45 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE:ABT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2018quarterly$0.281.85415114642828%4/12/20184/13/20185/15/2018
12/15/2017quarterly$0.281.99%1/11/20181/12/20182/15/2018
9/15/2017quarterly$0.272.05%10/12/201710/13/201711/15/2017
6/9/2017quarterly$0.272.25%7/12/20177/14/20178/15/2017
2/17/2017quarterly$0.272.36%4/11/20174/14/20175/15/2017
12/9/2016quarterly$0.272.7%1/11/20171/13/20172/15/2017
9/15/2016quarterly$0.262.48%10/12/201610/14/201611/15/2016
6/10/2016quarterly$0.262.75%7/13/20167/15/20168/15/2016
2/19/2016quarterly$0.262.66%4/13/20164/15/20165/16/2016
12/11/2015quarterly$0.262.32%1/13/20161/15/20162/16/2016
9/17/2015quarterly$0.242.22%10/13/201510/15/201511/15/2015
6/12/2015quarterly$0.242%7/13/20157/15/20158/15/2015
2/20/2015quarterly$0.242.03%4/13/20154/15/20155/15/2015
12/12/2014quarterly$0.242.21%1/13/20151/15/20152/13/2015
9/11/2014quarterly$0.222.07%10/10/201410/15/201411/15/2014
6/13/2014quarterly$0.222.21%7/11/20147/15/20148/15/2014
2/21/2014quarterly$0.222.26%4/11/20144/15/20145/15/2014
10/16/2013quarterly$0.222.37%1/13/20141/15/20142/15/2014
9/12/2013quarterly$0.141.61%10/10/201310/15/201311/15/2013
6/14/2013quarterly$0.141.52%7/11/20137/15/20138/15/2013
2/15/2013quarterly$0.141.61%4/11/20134/15/20135/15/2013
12/14/2012quarterly$0.140.86%1/11/20131/15/20132/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Abbott Laboratories (NYSE ABT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.76%
Institutional Ownership Percentage: 70.01%
Insider Trades by Quarter for Abbott Laboratories (NYSE:ABT)
Institutional Ownership by Quarter for Abbott Laboratories (NYSE:ABT)

Abbott Laboratories (NYSE ABT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/31/2018Brian J BlaserInsiderSell27,733$62.26$1,726,656.58156,587View SEC Filing  
1/30/2018Stephen R FussellEVPSell13,313$62.84$836,588.92152,343View SEC Filing  
12/14/2017Daniel Gesua Sive SalvadoriInsiderSell28,319$54.92$1,555,279.48102,117View SEC Filing  
12/6/2017Miles D WhiteChairmanSell276,886$54.41$15,065,367.263,677,913View SEC Filing  
11/30/2017Sharon J BrackenInsiderSell2,188$56.12$122,790.5625,618View SEC Filing  
11/22/2017Alejandro D WellischInsiderSell2,153$55.86$120,266.5810,256View SEC Filing  
11/17/2017Brian J BlaserInsiderSell23,866$55.55$1,325,756.30146,387View SEC Filing  
11/14/2017Daniel Gesua Sive SalvadoriInsiderSell71,157$55.00$3,913,635.00144,955View SEC Filing  
10/23/2017Daniel Gesua Sive SalvadoriEVPSell96,603$56.21$5,430,054.63142,082View SEC Filing  
9/26/2017Daniel Gesua Sive SalvadoriInsiderSell62,460$52.95$3,307,257.00113,426View SEC Filing  
9/22/2017Jaime ContrerasInsiderSell52,700$51.97$2,738,819.0058,739View SEC Filing  
8/16/2017Stephen R FussellInsiderSell196,550$49.50$9,729,225.00221,488View SEC Filing  
8/1/2017Sharon J BrackenInsiderSell2,000$49.16$98,320.0028,806View SEC Filing  
7/27/2017Brian J BlaserInsiderSell15,000$50.00$750,000.00143,154View SEC Filing  
7/25/2017Hubert L AllenInsiderSell4,600$50.79$233,634.00105,479View SEC Filing  
6/15/2017Jared WatkinInsiderSell552$47.97$26,479.4447,090View SEC Filing  
6/8/2017Stephen R FussellInsiderSell196,550$46.00$9,041,300.00221,488View SEC Filing  
4/27/2017Roger BirdInsiderSell5,600$43.82$245,392.0051,313View SEC Filing  
4/26/2017Joseph J ManningInsiderSell4,200$43.95$184,590.0026,224View SEC Filing  
3/1/2017Michael J. WarmuthInsiderSell3,851$45.39$174,796.89View SEC Filing  
2/23/2017Robert E FunckVPSell25,500$45.50$1,160,250.00117,579View SEC Filing  
2/22/2017Roger BirdInsiderSell13,222$45.02$595,254.4463,910View SEC Filing  
2/21/2017Deepak S NathInsiderSell319$44.98$14,348.6258,471View SEC Filing  
1/31/2017Heather L MasonInsiderSell35,700$40.77$1,455,489.00100,189View SEC Filing  
12/20/2016Brian J BlaserInsiderBuy15,580$38.45$599,051.00129,782View SEC Filing  
12/14/2016Robert B FordInsiderBuy12,775$39.09$499,374.7551,532View SEC Filing  
11/10/2016Miles D WhiteChairmanBuy121,456$40.45$4,912,895.202,802,558View SEC Filing  
11/1/2016Sally E BlountDirectorBuy5,100$39.24$200,124.0020,143View SEC Filing  
9/26/2016Daniel Gesua Sive SalvadoriSVPSell815$41.71$33,993.6559,791View SEC Filing  
7/28/2016Stephen R FussellInsiderSell41,500$45.00$1,867,500.00196,467View SEC Filing  
7/26/2016Michael J WarmuthInsiderSell26,800$43.49$1,165,532.0081,811View SEC Filing  
7/25/2016Miles D WhiteChairmanBuy242,547$43.18$10,473,179.462,010,517View SEC Filing  
7/25/2016Robert E FunckVPSell26,800$43.08$1,154,544.00111,819View SEC Filing  
6/28/2016Hubert L AllenEVPSell3,400$37.14$126,276.0091,857View SEC Filing  
6/15/2016Jared WatkinSVPSell552$37.63$20,771.7647,114View SEC Filing  
6/1/2016Brian B YoorCFOSell565$39.49$22,311.8550,182View SEC Filing  
4/28/2016Deepak S NathSVPSell53$41.31$2,189.4347,435View SEC Filing  
3/31/2016Jaime ContrerasSVPSell462$41.78$19,302.3647,667View SEC Filing  
2/29/2016Brian B YoorCFOSell865$39.12$33,838.8052,250View SEC Filing  
2/29/2016Deepak S NathSVPSell793$39.27$31,141.1148,364View SEC Filing  
2/29/2016Robert B FordEVPSell1,706$39.28$67,011.6862,495View SEC Filing  
2/29/2016Robert E FunckVPSell1,333$39.30$52,386.9086,352View SEC Filing  
2/22/2016Jared WatkinSVPSell554$39.09$21,655.8650,515View SEC Filing  
2/16/2016Deepak S. NathSVPSell171$37.13$6,349.2334,941View SEC Filing  
12/16/2015Miles D. WhiteCEOSell438,000$46.00$20,148,000.001,394,153View SEC Filing  
8/18/2015Stephen R. FussellEVPSell13,096$50.46$660,824.16130,601View SEC Filing  
4/27/2015Heather L MasonEVPSell13,500$47.45$640,575.00View SEC Filing  
4/27/2015Roger BirdSVPSell28,548$47.57$1,358,028.36View SEC Filing  
3/26/2015J. Scott WhiteSVPSell12,483$46.68$582,706.44View SEC Filing  
3/2/2015Jaime ContrerasSVPSell9,209$47.34$435,954.06View SEC Filing  
2/4/2015John M CapekEVPSell34,292$45.66$1,565,772.72View SEC Filing  
11/25/2014Jaime ContrerasSVPSell51,600$44.07$2,274,012.00View SEC Filing  
10/29/2014Miles D WhiteCEOSell440,800$42.52$18,742,816.00View SEC Filing  
3/3/2014John LandgrafEVPSell17,293$39.38$680,998.3495,131View SEC Filing  
3/3/2014Katherine DoyleSVPSell6,639$39.01$258,987.3947,525View SEC Filing  
3/3/2014Robert FunckVPSell1,413$38.97$55,064.6162,926View SEC Filing  
2/18/2014John LandgrafEVPSell1,583$39.10$61,895.30102,421View SEC Filing  
1/29/2014Michael WarmuthEVPSell11,430$36.21$413,880.3040,487View SEC Filing  
12/6/2013Jean-Yves PaveeSVPSell5,855$37.46$219,328.3030,901View SEC Filing  
11/7/2013Stephen FussellEVPSell10,466$37.59$393,416.94101,169View SEC Filing  
10/30/2013Jaime ContrerasSVPSell25,368$36.85$934,810.80View SEC Filing  
6/7/2013Heather L MasonSVPSell12,000$37.01$444,120.00View SEC Filing  
2/1/2013William A OsbornDirectorBuy10,000$33.86$338,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Abbott Laboratories (NYSE ABT) News Headlines

Source:
DateHeadline
Abbott Labs Declares Quarterly DividendAbbott Labs Declares Quarterly Dividend
finance.yahoo.com - February 19 at 5:07 PM
Abbott Declares 377th Consecutive Quarterly DividendAbbott Declares 377th Consecutive Quarterly Dividend
finance.yahoo.com - February 16 at 5:13 PM
Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2017Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 16 at 5:13 PM
Abbott Laboratories (NYSE:ABT): Does The -66.57% Earnings Decline Make It An Underperformer?Abbott Laboratories (NYSE:ABT): Does The -66.57% Earnings Decline Make It An Underperformer?
finance.yahoo.com - February 16 at 5:13 PM
Abbott Laboratories Jumps After Boosting Quarterly DividendAbbott Laboratories Jumps After Boosting Quarterly Dividend
finance.yahoo.com - February 16 at 5:13 PM
Abbott Laboratories Declares Quarterly Dividend of $0.28 (ABT)Abbott Laboratories Declares Quarterly Dividend of $0.28 (ABT)
www.americanbankingnews.com - February 16 at 12:56 PM
A Snapshot Of Abbott Labs BusinessA Snapshot Of Abbott Labs' Business
www.nasdaq.com - February 15 at 5:16 PM
Heartbreak And Desire: 11 Of Our Favorite Wall Street Love StoriesHeartbreak And Desire: 11 Of Our Favorite Wall Street Love Stories
finance.yahoo.com - February 14 at 3:31 PM
Abbott Laboratories (ABT) Given Consensus Recommendation of "Buy" by AnalystsAbbott Laboratories (ABT) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - February 14 at 11:54 AM
Will Medtronic See Lower Sales Again in 3Q18?Will Medtronic See Lower Sales Again in 3Q18?
finance.yahoo.com - February 14 at 7:19 AM
What Analysts Recommend for Medtronic ahead of 1Q18 EarningsWhat Analysts Recommend for Medtronic ahead of 1Q18 Earnings
finance.yahoo.com - February 14 at 7:19 AM
Abbott Laboratories (ABT) Short Interest Up 36.6% in JanuaryAbbott Laboratories (ABT) Short Interest Up 36.6% in January
www.americanbankingnews.com - February 13 at 1:58 AM
Abbott's FreeStyle LibreLink App Now Available in EuropeAbbott's FreeStyle LibreLink App Now Available in Europe
finance.yahoo.com - February 12 at 3:28 PM
See what the IHS Markit Score report has to say about Abbott Laboratories.See what the IHS Markit Score report has to say about Abbott Laboratories.
finance.yahoo.com - February 10 at 7:08 AM
Abbott Laboratories (ABT) Expected to Announce Quarterly Sales of $7.26 BillionAbbott Laboratories (ABT) Expected to Announce Quarterly Sales of $7.26 Billion
www.americanbankingnews.com - February 9 at 1:48 AM
Abbotts App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™
finance.yahoo.com - February 8 at 6:53 AM
With A Recent ROE Of 1.33%, Can Abbott Laboratories (NYSE:ABT) Catch Up To Its Industry?With A Recent ROE Of 1.33%, Can Abbott Laboratories (NYSE:ABT) Catch Up To Its Industry?
finance.yahoo.com - February 8 at 6:53 AM
Zacks: Analysts Anticipate Abbott Laboratories (ABT) Will Post Earnings of $0.58 Per ShareZacks: Analysts Anticipate Abbott Laboratories (ABT) Will Post Earnings of $0.58 Per Share
www.americanbankingnews.com - February 7 at 11:42 PM
Why Abbott Laboratories’ Product Pipeline Is Expected to Boost 2018Why Abbott Laboratories’ Product Pipeline Is Expected to Boost 2018
finance.yahoo.com - February 5 at 3:26 PM
Dividend Aristocrat Tailor-Made For Overheated Market - Seeking AlphaDividend Aristocrat Tailor-Made For Overheated Market - Seeking Alpha
seekingalpha.com - February 3 at 3:30 PM
Wall Street Analysts’ Recommendations for JNJ in January 2018Wall Street Analysts’ Recommendations for JNJ in January 2018
finance.yahoo.com - February 3 at 7:06 AM
Inside Abbott Laboratories’ 4Q17 Earnings Results: Key HighlightsInside Abbott Laboratories’ 4Q17 Earnings Results: Key Highlights
finance.yahoo.com - February 2 at 7:06 AM
Insider Selling: Abbott Laboratories (ABT) EVP Sells 13,313 Shares of StockInsider Selling: Abbott Laboratories (ABT) EVP Sells 13,313 Shares of Stock
www.americanbankingnews.com - February 1 at 6:10 PM
Brian J. Blaser Sells 27,733 Shares of Abbott Laboratories (ABT) StockBrian J. Blaser Sells 27,733 Shares of Abbott Laboratories (ABT) Stock
www.americanbankingnews.com - February 1 at 6:10 PM
Varian Medical Acquires Sirtex for $1.3 Billion: HighlightsVarian Medical Acquires Sirtex for $1.3 Billion: Highlights
finance.yahoo.com - February 1 at 3:27 PM
A Look at Johnson & Johnson’s 2018 GuidanceA Look at Johnson & Johnson’s 2018 Guidance
finance.yahoo.com - February 1 at 3:27 PM
ZBH’s 4Q17 Earnings Results Meet Analysts’ EstimatesZBH’s 4Q17 Earnings Results Meet Analysts’ Estimates
finance.yahoo.com - February 1 at 3:27 PM
Developments in J&J’s Medical Device Business Could Drive GrowthDevelopments in J&J’s Medical Device Business Could Drive Growth
finance.yahoo.com - January 31 at 3:28 PM
Citigroup Boosts Abbott Laboratories (ABT) Price Target to $64.00Citigroup Boosts Abbott Laboratories (ABT) Price Target to $64.00
www.americanbankingnews.com - January 30 at 10:16 PM
Abbott Laboratories (ABT) Price Target Raised to $80.00Abbott Laboratories (ABT) Price Target Raised to $80.00
www.americanbankingnews.com - January 30 at 10:25 AM
Leerink Swann Weighs in on Abbott Laboratories Q2 2018 Earnings (ABT)Leerink Swann Weighs in on Abbott Laboratories' Q2 2018 Earnings (ABT)
www.americanbankingnews.com - January 29 at 4:18 AM
Abbott Laboratories (ABT) Stock Rating Upgraded by William BlairAbbott Laboratories (ABT) Stock Rating Upgraded by William Blair
www.americanbankingnews.com - January 27 at 8:10 PM
Abbott Laboratories (ABT) PT Raised to $71.00Abbott Laboratories (ABT) PT Raised to $71.00
www.americanbankingnews.com - January 27 at 7:12 PM
Abbott Laboratories (ABT) Price Target Raised to $70.00 at Wells Fargo & CoAbbott Laboratories (ABT) Price Target Raised to $70.00 at Wells Fargo & Co
www.americanbankingnews.com - January 27 at 6:06 PM
Abbotts Acquisitive CEO Turns To Paying Debt, Boosting ResearchAbbott's Acquisitive CEO Turns To Paying Debt, Boosting Research
finance.yahoo.com - January 27 at 7:11 AM
6 Reasons Why William Blair Turned Bullish On Abbot Laboratories - Benzinga6 Reasons Why William Blair Turned Bullish On Abbot Laboratories - Benzinga
www.benzinga.com - January 26 at 3:28 PM
Abbott Labs (ABT) PT Raised to $71 at Stifel - StreetInsider.comAbbott Labs (ABT) PT Raised to $71 at Stifel - StreetInsider.com
www.streetinsider.com - January 26 at 3:28 PM
Abbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings Momentum - Investorplace.comAbbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings Momentum - Investorplace.com
investorplace.com - January 26 at 3:28 PM
How AbbVie Makes its MoneyHow AbbVie Makes its Money
finance.yahoo.com - January 26 at 3:28 PM
Gabelli Weighs in on Abbott Laboratories FY2018 Earnings (ABT)Gabelli Weighs in on Abbott Laboratories' FY2018 Earnings (ABT)
www.americanbankingnews.com - January 26 at 11:53 AM
Abbott Laboratories (ABT) Expected to Earn Q2 2018 Earnings of $0.72 Per ShareAbbott Laboratories (ABT) Expected to Earn Q2 2018 Earnings of $0.72 Per Share
www.americanbankingnews.com - January 26 at 9:32 AM
Abbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings MomentumAbbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings Momentum
investorplace.com - January 26 at 9:18 AM
Abbott Laboratories to Post Q1 2018 Earnings of $0.58 Per Share, Leerink Swann Forecasts (ABT)Abbott Laboratories to Post Q1 2018 Earnings of $0.58 Per Share, Leerink Swann Forecasts (ABT)
www.americanbankingnews.com - January 26 at 8:54 AM
Equities Analysts Offer Predictions for Abbott Laboratories Q1 2018 Earnings (ABT)Equities Analysts Offer Predictions for Abbott Laboratories' Q1 2018 Earnings (ABT)
www.americanbankingnews.com - January 26 at 8:44 AM
Why Analysts Keep Chasing Abbott Labs Higher and HigherWhy Analysts Keep Chasing Abbott Labs Higher and Higher
247wallst.com - January 26 at 7:00 AM
Increasingly Bullish Wall Street Ratings for ZBHIncreasingly Bullish Wall Street Ratings for ZBH
finance.yahoo.com - January 26 at 7:00 AM
6 Reasons Why William Blair Turned Bullish On Abbot Laboratories6 Reasons Why William Blair Turned Bullish On Abbot Laboratories
finance.yahoo.com - January 26 at 7:00 AM
Abbott Laboratories (ABT) PT Raised to $70.00 at Morgan StanleyAbbott Laboratories (ABT) PT Raised to $70.00 at Morgan Stanley
www.americanbankingnews.com - January 25 at 9:40 PM
Abbott Laboratories (ABT) Given New $69.00 Price Target at JPMorgan Chase & Co.Abbott Laboratories (ABT) Given New $69.00 Price Target at JPMorgan Chase & Co.
www.americanbankingnews.com - January 25 at 9:40 PM
Abbott Laboratories (ABT) Receives "Market Perform" Rating from Leerink SwannAbbott Laboratories (ABT) Receives "Market Perform" Rating from Leerink Swann
www.americanbankingnews.com - January 25 at 8:00 PM

SEC Filings

Abbott Laboratories (NYSE:ABT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Abbott Laboratories (NYSE:ABT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Abbott Laboratories (NYSE ABT) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.